Prof of Health Economics at ScHARR, University of Sheffield. Member of NICE Appraisal Committee. Like cycling and have haemophilia.
Joined November 2013
- Tweets1.5K
- Following344
- Followers1.1K
- Likes1.5K
Pinned Tweet
I made a movie about survival analysis and #HTA!
"What about a cure model?", set at Ultradrug Ltd.
youtu.be/oc2J2hfCLJQ
It's got a bit of KMunicate (@tmorris_mrc ), some stpm2 (@pclambert123, @MJRutherford9) and there's a special reward for anyone who makes it to the end
Nick Latimer retweeted
👩🏫 Join us at the #ISPORSummit for Prof. Nick Latimer's @NRLatimer talk on "Methods for Causal Inference Using Real-World Data "
📅 Sunday 17 November, 13:15 - 14:50.
💭 Enhance your #RWE knowledge with this insightful conversation.
🔗 buff.ly/3UGSSe2
Cure Models for HTA: What You Need to Know
Should decision-makers be more willing to use cure models? How do they work? What can go wrong? What on earth are flexible parametric non-mixture cure models??!
Thanks to @MJRutherford9 for writing this with me.
link.springer.com/article/10…
Nick Latimer retweeted
We are currently advertising for an early career researcher with a strong background in statistics/mathematics and an interest in Bayesian statistics and health technology assessment to join us at @SCHARRSheffield
G7, fixed-term until 31 March 2028
jobs.shef.ac.uk/sap/bc/webdy…
Nick Latimer retweeted
Treatment switching in randomised controlled trials: Trial design, what to adjust for, how, and reporting guidelines. The DSU’s new TSD 24 provides an update to TSD 16 – out now! shorturl.at/uJKMO
Nick Latimer retweeted
A publication from my doctoral work with my fantastic and inspiring supervisors Prof Nick Latimer @NRLatimer and Prof Jim Chilcott, and sponsored by the generous @wellcometrust.
@SCHARRSheffield @SCHARRHEDS
#HTA #treatmentsequennces #RWD #causalinference
Nick Latimer retweeted
🚨 Helpful how-to evaluate treatment sequences for #HTA by @SCHARRSheffield Amy Chang @NRLatimer
@ph_economics #pharmacoeconomics
link.springer.com/article/10…
ALT “Roadmap” of the treatment-sequencing literature in health technology assessments
Nick Latimer retweeted
Research by @NRLatimer and colleagues shows that forcing a marginal hazard ratio to 1 does not accurately assess mean survival difference under individual-level treatment effect waning. More at ow.ly/gHFY50QO0yc. #HEOR #HTA #harzardratio #ValueinHealth
Nick Latimer retweeted
If you're too busy to read 4000 words on moving data between countries, listen to my quick summary of key points in the video below.
@VivekSubbiah @NRLatimer #oncology
In a new article, experts from @Roche, @sheffielduni, @UniOfYork, & Flatiron discuss transportability, offering practical insights for decision-makers & emphasizing need for clear guidelines & further research to strengthen #HTA evaluations.
Read more: flatiron.com/resources/trans…
Nick Latimer retweeted
We are seeking leading cancer researchers to come & join us at Sheffield, in partnership with
@SheffieldHosp. You'll have a package of support inc research staff, consumables & PhD(s) + access to dedicated funding opportunities through
@yorkshirecancer 👉cancer-research-sheffield.co…
Some really great opportunities at Sheffield at the moment, including for methodologists.
📣 Join the University of Sheffield in the fight against cancer! 🎗️ We're recruiting top-notch cancer research leaders to help us create a future where more people survive and live longer.
Apply now at cancer-research-sheffield.co…
#Cancer #CancerResearch #oncology #epidemiology
Nick Latimer retweeted
📜Paper📜 in @BrainBehavior with @KRAbrams, @NRLatimer, @MichelaGuglieri, @MJRutherford9 and @Crowther_MJ.
Assessing the CPRD as a data resource for DMD (and other rare disease) natural history models:
✅ Mortality
❓ Intermediate events
doi.org/10.1002/brb3.3331
#rarediseases
Nick Latimer retweeted
***Fully Funded PhD Studentships*** We have 7 @wellcometrust Studentships in Public Health Economics and Decision Science available.
Check out our website for more information: pheds-dtc.ac.uk/
Deadline: 11th December 2023
Nick Latimer retweeted
📣 This time next week #ISPOREurope will be in full swing.
🔗 take a look at SCHARR's full academic programme buff.ly/3F5nwpb
😀 We hope you’ll pop by to see us on stand C2-021 in Hall E @ScHARRHEDS @ScHARRSheffield @ISPORorg
#ISPOR2023
Nick Latimer retweeted
12 days left until #HWSmethods2023 in @uni_mainz! Check out the program👇 with keynotes from @nkreif and @NRLatimer. You can still register via [email protected] - no participation fees thanks to @DGEpi_eV, @gmdsEV, @IBSstats, @DGSMP_e_V. #EpiTwitter #StatsTwitter
ALT Timetable of the workshop: sessions start on Nov 9 at 1 p.m. and end on Nov 10 at 1:30 p.m.
Nick Latimer retweeted
A big day 🤩
We've also launched:
👩🏫 A free course in survival analysis on our new Youtube channel
💻 A new #Stata package called #morgana for Bayesian flexible survival analysis
🧐 An advert for a new Principal Biostatistician to join the team
#Biostatistics
This Post is from an account that no longer exists. Learn more
Nick Latimer retweeted
Nice summary of our session ‘EHR - a good target’ which focussed on research design and methodologies for working with EHR. Great turnout and discussion #RSS2023Conf linkedin.com/posts/internati…
Nick Latimer retweeted
I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code.
Huge thanks to
@MJRutherford9 @danj_statsguru @NRLatimer @pclambert123 and all co-authors
doi.org/10.1177/0272989X2311…
Nick Latimer retweeted
A review of survival extrapolation methods with external evidence finds lots of methods, but little in the way of validation #hta #survivalanalysis
@AshBullement @gianlubaio @gemmaeshields @NRLatimer @ScHARRHEDS @stats_UCL @HealthEcon_MCR
bit.ly/423tcJG
Nick Latimer retweeted
New paper just out: we tend to always use the Hazard Ratio as population-level summary measure in clinical trials with survival outcomes. Is that always justified? [1/N] @tmorris_mrc @IanWhit25399993 @MaxParmarMRCUCL
journals.sagepub.com/doi/10.…
Nick Latimer retweeted
We are delighted to welcome Dr Caroline Mitchell @dclovesgp as co-lead of our cancer research theme on cancer prevention & early diagnosis, with @NRLatimer. With a better understanding of cancer in Yorkshire, we can develop targeted interventions & screening to improve survival.
